发明名称 Compositions for delivery of insoluble agents
摘要 Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium.
申请公布号 US8877746(B2) 申请公布日期 2014.11.04
申请号 US201013391440 申请日期 2010.08.24
申请人 Cardioklne, Inc 发明人 Chen Hailiang;Chen Andrew Xian;Frech Patricia;Abu-Izza Khawla;Schmidt Christoph
分类号 A61K31/55;A61K31/355;A01N43/62;A01N43/16;A61K47/22;A61K31/5517 主分类号 A61K31/55
代理机构 Brinks Gilson & Lione 代理人 Brinks Gilson & Lione
主权项 1. A pharmaceutical composition comprising a single oral dosage form including an oil-free and substantially water-free solid dispersion, the dispersion including a therapeutically effective amount of lixivaptan and 50% or more by weight of a vitamin E semi-ester.
地址 Cary NC US